Healthcare / Health Information ServicesTokyo
$691.00
-1.00 (-0.14%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 25% · confianza 25%
FCF escenarios
weak_data · normalized FCF $210.4M · quality 68.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
40/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
8/100
SEC 0%
Sin guardar todavía.
Market Cap
$3.6B
P/E
9.6x
↓EV/EBITDA
8.7x
↓ROE
27.0%
↑Gross Margin
81.1%
↑Debt/Equity
0.32
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2024–2025 · 1 años de histórico normalizado
Revenue CAGR
+10.2%
FCF CAGR
-18.1%
FCF margin
5.3%
FCF / Net income
0.99x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $3.55B · net income $192.3M · FCF $189.5M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 |
|---|---|---|---|
| Income Statement | |||
| Revenue | $3.55B | $3.55B | $3.22B |
| Net Income | $192.3M | $192.3M | $87.0M |
| EBITDA | $363.7M | $363.7M | $251.0M |
| EPS | — | — | 17.71 |
| Gross Margin | 81.1% | 81.1% | 81.1% |
| Operating Margin | 7.7% | 7.7% | 4.7% |
| Net Margin | 5.4% | 5.4% | 2.7% |
| Balance Sheet | |||
| Debt/Equity | 0.32 | 0.32 | 0.68 |
| Current Ratio | 3.73 | 3.73 | — |
| Cash Flow | |||
| Free Cash Flow | $189.5M | $189.5M | $231.4M |
| Returns | |||
| ROE | 27.0% | 27.0% | 16.7% |
| Valuation | |||
| P/E | 9.58 | 9.58 | — |
| EV/EBITDA | 8.72 | 8.72 | — |
| P/B | 4.76 | 4.76 | — |
| Growth & Yield | |||
| Revenue Growth | 10.2% | 10.2% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-40.8%
Start / end P/E
n/dx → n/dx
EPS bridge
17.71 → n/d
Residual
-40.8%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.